Scarica l'app Stockscreener
17.27
5.79%
0.945
Dopo l'orario di chiusura:
17.22
-0.05
-0.29%
Precedente Chiudi:
$16.32
Aprire:
$16.4
Volume 24 ore:
1.58M
Relative Volume:
5.66
Capitalizzazione di mercato:
$323.16M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-32.46%
1M Prestazione:
-18.38%
6M Prestazione:
-25.34%
1 anno Prestazione:
-9.91%
Intervallo 1D:
$15.34
$18.61
Intervallo di 1 settimana:
$15.34
$25.94
Portata 52W:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Nome
Tectonic Therapeutic Inc
Settore
Industria
Telefono
(339) 666-3320
Indirizzo
490 ARSENAL WAY, WATERTOWN
Confronta TECX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
17.27 | 311.56M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-04-21 | Iniziato | Mizuho | Outperform |
| 2024-11-20 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | TD Cowen | Buy |
| 2023-12-18 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-05 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-27 | Iniziato | Needham | Buy |
| 2021-03-09 | Iniziato | Barclays | Overweight |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-03-31 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2019-04-05 | Iniziato | Janney | Buy |
| 2018-10-10 | Iniziato | Guggenheim | Buy |
| 2018-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-17 | Iniziato | H.C. Wainwright | Buy |
| 2018-07-16 | Iniziato | Wedbush | Outperform |
| 2018-07-16 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Tectonic Therapeutic Inc Borsa (TECX) Ultime notizie
Can Tectonic Therapeutic Inc. stock double in the next yearJuly 2025 Pullbacks & Free Safe Entry Trade Signal Reports - khodrobank.com
Tectonic Therapeutic a new outperform at Oppenheimer on heart drug asset - Seeking Alpha
Insiders Re-Evaluate Their US$62.6m Stock Purchase As Tectonic Therapeutic Falls To US$478m - 富途牛牛
Can Tectonic Therapeutic Inc. recover in the next quarterQuarterly Growth Report & Expert Approved Momentum Ideas - Newser
Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate - Stocktwits
How to build a dashboard for Tectonic Therapeutic Inc. stockQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Oppenheimer initiates Tectonic Therapeutics stock with Outperform rating - Investing.com
Tectonic Therapeutic shares rise 2.28% premarket after Oppenheimer initiates coverage with an Outperform rating. - AInvest
Tectonic Therapeutic initiated with an Outperform at Oppenheimer - TipRanks
Oppenheimer Initiates Tectonic Therapeutic at Outperform With $80 Price Target - MarketScreener
Insider Purchases Worth US$62.6m See Losses As Tectonic Therapeutic Market Value Drops To US$478m - simplywall.st
Detecting price anomalies in Tectonic Therapeutic Inc. with AIEarnings Recap Report & AI Driven Stock Price Forecasts - Newser
Visualizing Tectonic Therapeutic Inc. stock with heatmaps2025 Institutional Moves & Weekly Watchlist for Hot Stocks - Newser
Visual analytics tools that track Tectonic Therapeutic Inc. performanceMarket Activity Recap & Precise Entry and Exit Recommendations - Newser
Does Tectonic Therapeutic Inc. show high probability of rebound2025 Momentum Check & Risk Adjusted Swing Trade Ideas - Newser
Technical signs of recovery in Tectonic Therapeutic Inc.2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Top chart patterns to watch in Tectonic Therapeutic Inc.Market Movers & Accurate Buy Signal Notifications - Newser
Will Tectonic Therapeutic Inc. bounce back from current support2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Should you hold or exit Tectonic Therapeutic Inc. nowInsider Selling & Consistent Profit Alerts - Newser
Why Tectonic Therapeutic Inc. is moving todayQuarterly Risk Review & Expert Curated Trade Setup Alerts - Newser
Tectonic pullback on Eli Lilly relaxin data ‘overdone,’ says Truist - MSN
Confidence in Tectonic Therapeutic’s Strategic Approach Amid Eli Lilly’s Trial Setback - TipRanks
Custom strategy builders for tracking Tectonic Therapeutic Inc.Market Performance Recap & Consistent Profit Alerts - Newser
Tectonic Therapeutic shares fall 31.75% intraday after reporting Q2 2025 earnings and industry-wide layoffs. - AInvest
Will Tectonic Therapeutic Inc. benefit from rate cutsTrade Analysis Report & Consistent Profit Trading Strategies - khodrobank.com
Short interest data insights for Tectonic Therapeutic Inc.Portfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Backtesting results for Tectonic Therapeutic Inc. trading strategies2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Is now a turning point for Tectonic Therapeutic Inc.Earnings Summary Report & Accurate Entry/Exit Alerts - Newser
Using data models to predict Tectonic Therapeutic Inc. stock movementMarket Weekly Review & Momentum Based Trading Ideas - Newser
Can Tectonic Therapeutic Inc. be the next market leaderMarket Sentiment Review & Capital Efficient Trading Techniques - khodrobank.com
What is the dividend yield of Tectonic Therapeutic Inc.Quarterly Earnings Report & Free Community Consensus Stock Picks - khodrobank.com
Institutional scanner results for Tectonic Therapeutic Inc.2025 Institutional Moves & Community Verified Swing Trade Signals - Newser
Ranking Tectonic Therapeutic Inc. among high performing stocks via tools2025 Price Momentum & High Return Stock Watch Alerts - Newser
Historical volatility pattern of Tectonic Therapeutic Inc. visualized2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Signal strength of Tectonic Therapeutic Inc. stock in tech scannersPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Tectonic Therapeutic Inc Azioni (TECX) Dati Finanziari
Non sono disponibili dati finanziari per Tectonic Therapeutic Inc (TECX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Tectonic Therapeutic Inc Azioni (TECX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
45,858 |
767,204 |
1,449,652 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
21,071 |
311,020 |
1,403,794 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
16.31 |
9,478 |
154,586 |
4,334,846 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
8,092 |
135,379 |
4,325,368 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
3,718 |
54,880 |
4,317,276 |
| SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
412,500 |
7,053,750 |
1,382,723 |
| SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
87,500 |
1,496,250 |
4,313,558 |
| MCGUIRE TERRANCE | Director |
Apr 07 '25 |
Sale |
17.10 |
500,000 |
8,550,000 |
573,062 |
| SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
50.00 |
660,000 |
33,000,000 |
970,223 |
| SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
54.14 |
129,294 |
6,999,977 |
4,226,058 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):